CAS
IMGN

Coppell Advisory Solutions’s Immunogen Inc IMGN Stock Holding History

Coppell Advisory Solutions’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$31.7K Buy
+1,068
New +$21.3K 0.01% 606

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Coppell Advisory Solutions's IMGN Position: Q4 2023 in Review

Coppell Advisory Solutions opened a new position in Immunogen Inc (IMGN) in Q4 2023: 1,068 shares worth $31.7K. The stake represents 0.01% of the portfolio and ranks #606 among its holdings.

327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Coppell Advisory Solutions held 1,068 shares of Immunogen Inc worth $31.7K as of Q4 2023.
  • Immunogen Inc was a new Coppell Advisory Solutions position in Q4 2023.
  • Immunogen Inc made up 0.01% of Coppell Advisory Solutions's portfolio in Q4 2023, its #606 holding.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Coppell Advisory Solutions's 13F filing for Q4 2023, filed 14 Feb 2024.